# Hybrid intelligent systems for liver disease prediction: a demographic-aware machine learning framework

## TL;DR

This paper introduces a machine learning framework that uses demographic data to improve early detection of liver disease with high accuracy.

## Contribution

A novel hybrid intelligent system that integrates demographic segmentation with machine learning for personalized liver disease prediction.

## Key findings

- The framework achieved 94.2% accuracy on the ILPD dataset and 99.8% on a large-scale dataset.
- Demographic segmentation improved model performance across age and gender groups.
- Feature analysis showed varying biomarker importance by demographic factors.

## Abstract

Liver disease remains a major global health burden, often progressing undetected until advanced stages. Traditional diagnostic approaches, while accurate, are invasive, costly, and limited in accessibility.

To address these challenges, we propose a hybrid intelligent framework that integrates demographic segmentation with advanced machine learning for the early detection of liver disease.

Two datasets were employed, including the Indian Liver Patient Dataset (ILPD, n = 583) and a large-scale dataset (n = 29,787). Patients were stratified by age and gender into six groups, enabling segment-specific model development. Sixteen algorithms, including Random Forest, Support Vector Machines, XGBoost, and LightGBM, were evaluated using recursive feature elimination, resampling techniques, and Bayesian hyperparameter optimization. Segment-specific best models were integrated into a hybrid system through dynamic selection and ensemble strategies. The framework achieved 94.2% accuracy on ILPD and 99.8% on the large dataset, with consistent improvements across demographic groups. Feature analysis revealed distinct biomarker importance by age and gender, underscoring the need for tailored diagnostic approaches..

By combining demographic awareness, hybrid learning, and interpretability, this study offers a scalable, non-invasive, and clinically relevant tool for early detection of liver diseases, advancing personalized and accessible healthcare.